Vasoconstriction Trial With LEO 90100 Aerosol Foam

NCT02973776 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 90100 aerosol foam
DRUG: Dermoval®/Dermovate®
DRUG: Diprosone
DRUG: Elocon
DRUG: Locoid
OTHER: LEO 90100 foam vehicle

Sponsor

LEO Pharma